Clinical Trials Browser

Phase 2 × saracatinib × Sarcoma × Clear all

NCT00752206 2020-01-18

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Phase 2 Terminated

38 enrolled 10 charts

Sarcoma

Recurrence, Osteosarcoma

NCT00659360 2018-06-29

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

Phase 2 Completed

17 enrolled 9 charts

GynecologicSarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Endometrial Stromal, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous